Compounds for use as orally active anaphylactic inhibitors are disclosed. The compounds are trans-2,3b,4,5,7,8b,9,10-octahydronaphto 1,2- c:5,6-c'! dipyrazoles which may be substituted in both of the pyrazole rings. Also disclosed are intermediate compounds which are the corresponding trans-2,6-bis (hydroxymethylene) decalin-1,5-diones.
展开▼